Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 5;19(23):16268.
doi: 10.3390/ijerph192316268.

Impact of Paraben Exposure on Adiposity-Related Measures: An Updated Literature Review of Population-Based Studies

Affiliations
Review

Impact of Paraben Exposure on Adiposity-Related Measures: An Updated Literature Review of Population-Based Studies

Xinyun Xu et al. Int J Environ Res Public Health. .

Abstract

Parabens are alkyl esters of p-hydroxybenzoic acid that are commonly used in pharmaceutical and cosmetic products. Humans are exposed to parabens when they use these products and through diet. There are growing concerns that paraben exposure can adversely impact human health. The endocrine-disrupting and obesogenic properties of parabens have been observed in animal studies and in vitro, prompting the increase in population-based studies of paraben exposure and adiposity-related endpoints. In this review, we summarize epidemiological studies published between 2017 and 2022 that examined paraben exposure in utero, between birth and adolescence, and in adulthood, in relation to adiposity-related measures. Overall, these studies provide some evidence that suggests that paraben exposure, especially during critical development windows, is associated with adiposity-related measures. However, we have noted several limitations in these studies, including the predominance of cross-sectional studies, inconsistent sample collection procedures, and small sample sizes, which should be addressed in future studies.

Keywords: adiposity-related measures (ARM); endocrine disruptors; human exposure; parabens; population-based studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Matwiejczuk N., Galicka A., Brzoska M.M. Review of the safety of application of cosmetic products containing parabens. J. Appl. Toxicol. 2020;40:176–210. doi: 10.1002/jat.3917. - DOI - PubMed
    1. Tade R.S., More M.P., Chatap V., Deshmukh P., Patil P. Safety and toxicity assessment of parabens in pharmaceutical and food products. Inventi Rapid Pharm. Pract. 2018;3:1–9.
    1. Review C.I. Final report on the safety assessment of methylparaben, ethylparaben, propylparaben, and butylparaben. J. Am. Coll. Toxicol. 1984;3:147–209.
    1. Bledzka D., Gromadzinska J., Wasowicz W. Parabens. From environmental studies to human health. Environ. Int. 2014;67:27–42. doi: 10.1016/j.envint.2014.02.007. - DOI - PubMed
    1. Fisher M., MacPherson S., Braun J.M., Hauser R., Walker M., Feeley M., Mallick R., Berube R., Arbuckle T.E. Paraben Concentrations in Maternal Urine and Breast Milk and Its Association with Personal Care Product Use. Environ. Sci. Technol. 2017;51:4009–4017. doi: 10.1021/acs.est.6b04302. - DOI - PubMed